NEW YORK (GenomeWeb News) – Pharmacogenomics firm AssureRx Health announced on Wednesday it has closed its Series C financing, raising $12.5 million.

The funding will go toward commercialization of its GeneSightRx Psychotropic and GeneSightRx ADHD tests as well as the development of new tests, the Mason, Ohio-based company said. AssureRx President and CEO James Burns added that the proceeds will be used to expand sales coverage, sponsor multiple clinical studies, and develop new products "to help accelerate our leadership position in psychiatric personalized medicine."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.